Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cibus, Inc.CLXT · Entity 6658 | Chief Commercial Officer | July 01, 2019 | July 02, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cibus, Inc.
Report date July 01, 2019 · Filed July 02, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 65,323 |
Reported balance
After 2019-07-01 transaction · row 1
1 source rowRow 1 · 2019-07-01 · Sale · Disposed 1,494 · Balance 65,323 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2019. F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.58 to $12.80, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2019.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.58 to $12.80, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2019 Filed Jul 2, 2019 17:20 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 1,494 | $12.70 | $18,967.08 |
DisclosureSEC source: 0001615594-19-000028 · primary_doc.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,323 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2019. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.58 to $12.80, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. Read SEC document |
| May 13, 2019 Filed May 15, 2019 22:07 UTC | Cibus, Inc. CLXT · Entity 6658 | GrantStock Option (Right to Buy) · Derivative | 68,000 | $0.00 Strike: $15.28 | $0.00 |
DisclosureSEC source: 0001127602-19-018607 · form4.xml · derivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,000 Underlying: Common Stock · 68,000 shares Expires 2029-05-13 F1 · derivative.exercise_date: The Stock Option was granted on May 13, 2019 and vests 15% on the first anniversary of the grant date and 10% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 45 months (commencing on September 30, 2021). Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 12:38 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 1,522 | $17.33 | $26,378.09 |
DisclosureSEC source: 0001127602-19-013927 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2019. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.03 to $17.67, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 53,900 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 33 months. Read SEC document |
| March 20, 2019 Filed Mar 21, 2019 20:07 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 3,262 | $18.00 | $58,716.00 |
DisclosureSEC source: 0001127602-19-012652 · form4.xml · nonDerivative · entry 2 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F2 · balance_after: Includes 58,800 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 36 months. Read SEC document |
| March 19, 2019 Filed Mar 21, 2019 20:07 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 5,068 | $18.00 | $91,224.00 |
DisclosureSEC source: 0001127602-19-012652 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,601 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F2 · balance_after: Includes 58,800 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 36 months. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:03 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 2,444 | $10.39 | $25,388.76 |
DisclosureSEC source: 0001127602-19-001258 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,669 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.16 to $10.63, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 58,800 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 36 months. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 22:25 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 2,521 | $14.84 | $37,416.18 |
DisclosureSEC source: 0001127602-18-029474 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,113 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.7019 to $14.96, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · balance_after: Includes 63,700 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 42 months. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 19:08 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 490 | $20.51 | $10,049.90 |
DisclosureSEC source: 0001127602-18-021363 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,634 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2017. F2 · balance_after: Includes 68,600 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 42 months. Read SEC document |
| June 15, 2018 Filed Jun 15, 2018 22:22 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 5,096 | $19.49 | $99,321.04 |
DisclosureSEC source: 0001127602-18-021070 · form4.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,124 F1 · shares: Represents the sale of shares to Cellectis, S.A. pursuant to a Share Purchase Agreement, dated June 13, 2018, among the reporting person, Cellectis, S.A. and the issuer to cover tax obligations of the reporting person in connection with the vesting on June 14, 2018 of restricted stock units ("RSUs") granted by the issuer to the reporting person. F2 · balance_after: Includes 68,600 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017, remain unvested and will vest quarterly in equal installments over the following 42 months. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:53 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 4,900 | $19.13 | $93,729.65 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 5 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,220 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00-19.41, inclusive. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:53 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 980 | $19.51 | $19,121.17 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 4 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,120 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.13-19.82, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 400 | $21.92 | $8,768.00 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 3 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,100 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.88-21.96, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 1,646 | $21.20 | $34,900.30 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 2 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.80-21.68, inclusive. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:53 UTC | Cibus, Inc. CLXT · Entity 6658 | SaleCommon Stock | 2,854 | $20.22 | $57,693.90 |
DisclosureSEC source: 0001615594-18-000014 · primary_doc.xml · nonDerivative · entry 1 Sahoo Manoj · CIK 0001712226 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,146 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 21, 2017. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.79-20.72, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2-6 to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.